Supporters for medical marijuana frequently get involved in political performance to modify

Supporters for medical marijuana frequently get involved in political performance to modify the policy. Many patients stay silent with their suffering from medical conditions where everything has failed and turned to cannabis. Doctors and Practitioners may have expressed their moral opinions and logical positions regarding the substance and the minimal data available. Marijuana has still not received any formal evaluations in any clinical trials by the government (Mouhamed et al., 2018). However, efficacy and safety studies have been in progress, but additional studies are required to proceed with a policy regarding its medicinal and treatment use. Currently, many practices are using it for therapeutic cannabinoid treatment options for patients with cancer, HIV/AIDS for nausea, vomiting, appetite inducer, and pain control (Mouhamed et al., 2018).Article 1Abrams, D. (2016). Using medical cannabis in an oncology practice. Oncology, 30(5), 397-404.Summary on “Using Medical Cannabis in an Oncology Practice” The purpose of the investigation and trial stems from the lack of gold-standard data from any forthcoming randomized measured clinical trial for medicinal Cannabis is in existent. The National Institute on Drug Abuse (NIDA) is the only agency in the United States (US) that can to conduct such trials. However, the NIDA currently have congressional mandate to study substances as abuse content but not study the drug as treatment options (Abrams, 2016). Unfortunately, in the absence of clinical trials here has paved way for practices to be using the extracted Cannabidiol (CBD) to apply it as analgesic and anti-inflammatory therapies without it being the standard. There were only three studies to investigate Cannabis and two had failed (Abrams, 2016). Sample information is inconclusive since no randomized investigation was completed in the United State. According the Abrams, Cannabis is now available for medical use in 23 states and the District of Columbia. California was the first state to approve medicinal cannabis in 1996. Over the past 2 decades, half of the states, accounting for 86% of the US population, have acquired access to cannabis as medicine (Abrams, 2016). The writer hope is more data will be generated from observational or interventional trials soon. Which will allow doctors to feel even more confident recommending this ancient botanical to their patients (Abrams, 2016). Personally, the article has been very informative and enlightened on my part. Since, elsewhere in the world have successful study on most of the Cannabis with good results, US should accept the drug to be used in therapeutic treatments for needed patients.Article 2Zolotov, Vulfsons, Zarhin, & Sznitman. (2018). Medical cannabis: An oxymoron? Physicians’ perceptions of medical cannabis. International Journal of Drug Policy, 57, 4-10.Summary on “Medical cannabis: An oxymoron? Physicians’ perceptions of medical cannabis”The purpose of this study is developing a profound understanding of providers’ opinions on medical cannabis; and probably incorporating the substance in clinics treatments, as well as to identifying the possible fundamental reasons that influence these observations (Zolotov et al., 2018). The method of the study bases it’s the narrative on a qualitative analysis of in-depth interviews with twenty-four Israeli physicians from three specialties in oncology, family practice, and pain management. The sample size of twenty-four individuals ranged from gender, ages from four to thirty-three (4-33), condition participated in the studies (Zolotov et al., 2018). The findings of the study pointed out to physicians emphasizes positive hands-on experiences with cannabis, and pointed to the limits of conventional medicine. They also indicated cannabis as a non-medicine, and physicians drew on traditional medicine and prohibition as narrative environments (Zolotov et al., 2018). The researchers did not have a consolidated perspective as to whether marijuana “cannabis”” is a drug or not but somewhat fought with this question. The dualistic descriptions of drugs reflect on the lack of a dominant narrative environment that supports the integration of cannabis into medical practice. The substance is enclosed in the dual row of medical marijuana but remains harmful at the same time

Our dedicated nursing writer will craft your paper of
any complexity
FOR YOU

just from only $13.90/page


order my paper

Leave a Reply

Your email address will not be published.

x

Hello, dear nurse!

We are happy to help with your assignment, so please place your order using the link below!

Click here to proceed